America's rapid depletion of anti-air interceptor missile inventory, particularly SM-2, SM-6, PAC-3, and AIM-120 AMRAAMs, now influences broader strategic planning, especially in Asia. Operations in the Middle East, including Operation Rough Rider, Operation Epic Fury against Iran, and consistent support for Israeli air defenses post-October 7, have consumed advanced interceptors far faster than the US defense industrial base can replace them.
RTX produces only 125-200 SM-6 missiles annually, while Lockheed Martin makes 550-650 PAC-3s per year. The Ukraine war already forced the US to reroute PAC-3 exports, and the Middle East crisis exacerbated shortages. Industrial bottlenecks, not money, are the primary constraint, specifically solid rocket motors, skilled labor requiring years of training and security vetting, and precision tooling. The industrial base was optimized for peacetime procurement, not wartime surges. Despite increased funding, SM-6 inventories won't be restored until 2028-2029, PAC-3 until mid-2029, and Tomahawk until 2030, with many interceptors requiring two years from component production to delivery. This lag has significant strategic consequences, as every interceptor used in the Middle East is unavailable for a potential conflict involving China in the Pacific.
No comments:
Post a Comment